# Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation

> **NCT05320627** · PHASE4 · COMPLETED · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 150 (actual)

## Conditions studied

- Non-Valvular Atrial Fibrillation

## Interventions

- **DRUG:** Edoxaban

## Key facts

- **NCT ID:** NCT05320627
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-30
- **Primary completion:** 2024-08-30
- **Final completion:** 2024-10-30
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2026-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05320627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05320627, "Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05320627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*